SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Total Debt History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹8.46 Cr | ₹19 Cr | ₹7.52 Cr | ₹8.79 Cr | ₹9.41 Cr |
What is the latest Total Debt ratio of SAMRAT PHARMACHEM ?
Year | Total Debt |
---|---|
Mar2024 | ₹8.46 Cr |
Mar2023 | ₹19 Cr |
Mar2022 | ₹7.52 Cr |
Mar2021 | ₹8.79 Cr |
Mar2020 | ₹9.41 Cr |
How is Total Debt of SAMRAT PHARMACHEM Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹8.46 Cr | -54.69 | |
Mar2023 | ₹19 Cr | 148.13 | |
Mar2022 | ₹7.52 Cr | -14.49 | |
Mar2021 | ₹8.79 Cr | -6.54 | |
Mar2020 | ₹9.41 Cr | - |
Compare Total Debt of peers of SAMRAT PHARMACHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAMRAT PHARMACHEM | ₹98.6 Cr | -3.9% | -17.3% | -10.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
SAMRAT PHARMACHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAMRAT PHARMACHEM | -3.9% |
-17.3% |
-10.2% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses